We report a case of spontaneous clearance of hepatitis C virus (HCV) in a patient co-infected for 20 years with HCV and HIV, and with an chronic active hepatitis C never treated with anti-HCV regimens. We review the literature of eight anecdotal reports describing the spontaneous resolution of chronic HCV infection among HIV-infected patients, and discuss the virological, immunological, pathogenetic and therapeutic implications of this observation.
CooperCL, CameronDW. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Clin Infect Dis2002;35:873–9
2.
RutschmannOT, NegroF, HirschelB, HadengueA, AnwarD, PerrinLH. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis1998;177:783–5
3.
KozielMJ, PetersMG. Viral hepatitis in HIV infection. New Engl J Med2007;356:1445–54
4.
ManfrediR. Coinfection with HIV and hepatitis C virus and immune restoration. Clin Infect Dis2006;42:298–9
5.
FranchiniM, MengoliC, VeneriD, MazziR, LippiG, CrucianiM. Treatment of chronic hepatitis C in haemophilic patients with interferon and ribavirin. A meta-analysis. J Antimicrob Chemother2008;61:1191–200
6.
FialaireP, PayanC, VitourD, Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection. J Infect Dis1999;180:574–5
7.
WeissbrichB, LangmannP, SchubertJ, JassoyC, KlinkerH. Resolution of HCV infection in a HIV-infected patient under HAART after several hepatitis flare-ups. Eur J Med Res2003;8:495–8
8.
TortiC, BarnesE, Quiros-RoldanE, PuotiM, CarosiG, KlenermanP. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection. Antivir Ther2004;9:139–42
9.
ZietounJD, MalletV, ChaixML, ViardJP, BlancheS, PolS. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. J Clin Virol2007;40:71–3
10.
De RosaFG, AudagnottoS, BargiacchiO, Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. J Infect2006;53:e215–8
11.
FalconerL, GonzalezVD, ReichardO, SandbergJK, AlaeusA. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol2008;41:160–3
12.
EndoT, FujimotoK, NishioM, Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. J Med Virol2009;81:979–82
13.
Martín-CarboneroL, BarreiroP, Jiménez-GalánG, Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis. J Viral Hepat2007;14:392–5
14.
MaidaI, RíosMJ, Pérez-SalemeL, Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era. AIDS Res Hum Retroviruses2008;24:679–83
15.
Matsiota-BernardP, VrioniG, OnodyC, BernardL, De TruchisP, PeronneC. Human immunodeficiency virus (HIV) protease inhibitors have no effect on hepatitis C (HCV) serum levels of HIV-HCV co-infected patients. Int J Antimicrob Agents2001;17:155–7
16.
Liu-YoungG, KozalMJ. Hepatitis C protease and polymerase inhibitors in development. AIDS Patient Care STDs2008;22:449–57
17.
TsantrizosYS. Peptidomimetic therapeutic agents targeting the protease enzyme of the human immunodeficiency virus and hepatitis C virus. Acc Chem Res2008;41:1252–63
18.
SeminariE, De BonaA, GentiliniG, Amprenavir and ritonavir plasma concentrations in HIV-infected patients treated with fosamprenavir/ritonavir with various degrees of liver impairment. J Antimicrob Chemother2007;60:831–6
19.
GattiF, NastaP, LoregianA, Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. J Antimicrob Chemother2009;63:575–8
